T +48 22 50 50 138
Jakub Gubański focuses his practice on competition law matters and mergers & acquisitions.
Since the beginning of his legal career at White & Case, Jakub has provided legal advice on the antimonopoly aspects of cross-border concentrations of business entities, in particular, on the energy, insurance, healthcare, telecommunication, media, IT and real estate markets.
He has advised numerous companies on the merger control rules in Poland and provided guidance in relation to compliance with antitrust and competition law in the EU and Poland. He has also represented clients in the process of obtaining the approval of the relevant competition authorities.
In 2007 Jakub was seconded to the White & Case Brussels office, where he focused on European law, including, in particular, competition law. He also assisted in antitrust proceedings before the European Commission and the European Court of Justice.
Jakub has also worked on numerous acquisitions of public and private companies, including banks, insurance companies, IT, energy and FMCG companies, as well as the privatization of companies. He has also represented various private equity funds in a large number of acquisitions of Polish portfolio companies. Jakub has also advised on internal reorganizations of capital groups and the formation of joint ventures.
Represented KI Chemistry s.à r.l., a subsidiary of Kulczyk Investments S.A., in connection with the acquisition of a majority of shares in CIECH S.A., the leading European chemical company and the second largest producer of soda ash in Europe. The transaction was carried out by way of a tender offer for the acquisition of up to 66% of the issued share capital of CIECH S.A. Value of the transaction: PLN 835 million (USD 278 million).
Represented Roust Trading Ltd. in connection with the acquisition of CEDC.
Represented BUPA in connection with the acquisition of Lux Med.
Advised Alior Bank S.A. and Erste Bank on compliance with competition laws in connection with the financial restructuring of Polbita sp. z o.o.
Represented Sanofi-Aventis in connection with the acquisition of Nepentes.
For the last several years, the prestigious ranking The Legal 500 EMEA has recommended Jakub in the Competition/Antitrust category.
Jakub's articles have been published in Crime, Law and Social Change, Gazeta Finansowa and The Wall Street Journal Polska.